Trials / Unknown
UnknownNCT05478473
Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study was a single-arm study designed to evaluate the efficacy and safety of Chidamide combined with Toripalimab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chidamide combined with Toripalimab | chidamide：oral, 30 mg/time, twice weekly; Toripalimab：intravenous drip, 240mg, once every 3 weeks |
Timeline
- Start date
- 2022-10-27
- Primary completion
- 2023-08-01
- Completion
- 2024-08-01
- First posted
- 2022-07-28
- Last updated
- 2023-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05478473. Inclusion in this directory is not an endorsement.